Compare NRP & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRP | AORT |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2002 | 1996 |
| Metric | NRP | AORT |
|---|---|---|
| Price | $118.64 | $35.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.40 |
| AVG Volume (30 Days) | 14.7K | ★ 332.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | $216,119,000.00 | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ $11.28 | $171.95 |
| Revenue Growth | ★ 54.66 | 18.01 |
| 52 Week Low | $92.00 | $24.53 |
| 52 Week High | $128.60 | $48.25 |
| Indicator | NRP | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 44.79 |
| Support Level | $117.31 | $34.97 |
| Resistance Level | $123.40 | $38.02 |
| Average True Range (ATR) | 2.43 | 1.45 |
| MACD | 0.44 | -0.17 |
| Stochastic Oscillator | 100.00 | 22.88 |
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.